Table of Contents Table of Contents
Previous Page  92 / 1096 Next Page
Information
Show Menu
Previous Page 92 / 1096 Next Page
Page Background

S79

ESTRO 36

_______________________________________________________________________________________________

OC-0156 Automated reference-free local error

assessment in clinical multimodal deformable image

registration

M. Nix

1

, R. Speight

1

, R. Prestwich

2

1

St James' Institute of Oncology, Radiotherapy Physics,

Leeds, United Kingdom

2

St James' Institute of Oncology, Clinical Oncology,

Leeds, United Kingdom

Purpose or Objective

Multimodal deformable image registration (MM-DIR), for

MR-CT fusion in RT planning, is a difficult problem.

Algorithms in commercial applications can leave

significant residual errors and performance can vary

considerably through a 3D image set. Currently, quality

assessment relies on clinical judgement or time-

consuming landmarking approaches for quantitative

comparison. Due to the variability of MM-DIR performance,

a pre-clinical commissioning approach cannot be relied

upon to quality assure clinical performance. The primary

objective was to develop and validate an automated

method for localised error assessment of clinical

multimodal deformable image registrations, without

reference data. This should aid clinical judgement of

registration reliability across the volumetric data and

hence increase clinical confidence in MM-DIR fusion for RT

planning.

Material and Methods

A computational method for determining the local

reliability of a given clinical registration has been

developed. Two registration assessment algorithms, using

blockwise mutual information (BMI) and pseudo-modal

cross correlation (pmCC) respectively, have been

implemented and compared. Error information is

presented as a quantitative 3D ‘iso-error’ map, showing

areas of a registered dataset where errors are greater than

a certain magnitude and may not be reliable, e.g. for

contouring tumour or organ at risk volumes. The

developed software was validated using a ‘gold-standard’

rigidly-registered image set, derived from immobilised

MR, registered to immobilised CT, which was deformed

with known rotations, translations and more complex

deformation fields. Detected and applied errors were

compared across the dataset. Mean errors within the GTVs

of 14 head and neck MR-CT registrations were analysed

using the BMI method and used to identify cases where the

registration may be clinically unacceptable.

Results

Both algorithms consistently detected applied errors

larger than 2 mm. Errors detected using the BMI method,

following intentional rotation of gold-standard pre-

registered clinical MR data, were strongly correlated with

applied errors, in magnitude and direction (Pearson’s r >

0.96).

Analysis in the direction orthogonal to the applied

deformation showed minimal errors, as expected ( <E> =

0.32 mm, SD = 0.43 mm). Across 14 clinical MR-CT

registration datasets, mean magnitude registration errors

within the GTV varied from 0.4 to 5.4 mm (population

mean = 1.8 mm), indicating that MM-DIR errors can be

significant for RT planning.

Conclusion

Reference free localised registration quality assessment

offers clinicians a tool to judge registration reliability,

which could increase confidence in and clinical usage of

MM-DIR in radiotherapy. A software tool was developed

and validated to achieve this. A strong correlation was

found between detected and applied registration errors.

Mean GTV error is a potential indicator for clinical

acceptability of registrations.

OC-0157 Atlas-based segmentation of prostatic urethra

in the planning CT of prostate cancer

O. Acosta

1

, M. Le Dain

1

, C. Voisin

1

, R. Bastien

1

, C. Lafond

2

,

K. Gnep

2

, R. De Crevoisier

2

1

LTSI-INSERM UMR 1099, Université de Rennes 1, Rennes,

2

Centre Eugene Marquis, Radiotherapy, Rennes, France

Purpose or Objective

to the dose delivered mainly to the bladder) and likely

also to the urethra (obstructive symptoms). Identification

of urethra for dose assessment from planning CT scans is

however challenging as the organ lies inside the prostate

and is not visible. Moreover, the dose received by the

urethra may not be superposed to the dose received by

the whole prostate. In case of prostate IMRT, the goals of

this work were therefore: i) to propose an automatic

method for urethra segmentation from the planning CT

and ii) to quantify the dose received by the urethra.

Material and Methods

An original weighted multi atlas-based segmentation

method was devised standing on a global characterization

of the urethra wrt the surrounding organs. For building the

atlas a first set of CT scans (512×512 0.63×0.63 mm axial

pixels and 3 mm slices) from 80 patients treated for

localized prostate cancer with Iodine 125 brachytherapy

was used. All the patients had an urinary probe allowing

an ease manual urethra segmentation. Prostate, bladder

and urethra were delineated by a radiation oncologist. An

average patient, in terms of prostate volume, was

selected as common reference system where all the

patients were rigidly aligned. Each segmented urethra was

characterized by its central line, the relative bladder

position and prostate characteristics (height, excentricity

and volume). An in-house demons based registration using

prostate contours and Laplacian maps was performed to